Ebiratide
Code | Size | Price |
---|
TAR-TP2379-100mg | 100mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-TP2379-500mg | 500mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C
Images
Documents
Further Information
Bioactivity:
Ebiratide is an analog of ACTH 4-9.
CAS:
105250-86-0
Molecular Weight:
996.23
Purity:
0.98
SMILES:
N([C@@H](CC1=CC=CC=C1)C(N)=O)(C([C@H](NC([C@H](CC2=CC=CC=C2)NC([C@H](CC3=CN=CN3)NC([C@@H](NC([C@H](CCS(C)(=O)=O)N)=O)CCC(O)=O)=O)=O)=O)CCCCN)=O)CCCCCCCCN
References
Yamamoto A, Okagawa T, Kotani A, Uchiyama T, Shimura T, Tabata S, Kondo S, Muranishi S. Effects of different absorption enhancers on the permeation of ebiratide, an ACTH analogue, across intestinal membranes. J Pharm Pharmacol. 1997 Nov;49(11):1057-61. PubMed PMID: 9401937.
Shimura T, Tabata S, Ohnishi T, Terasaki T, Tsuji A. Transport mechanism of a new behaviorally highly potent adrenocorticotropic hormone (ACTH) analog, ebiratide, through the blood-brain barrier. J Pharmacol Exp Ther. 1991 Aug;258(2):459-65. PubMed PMID: 1650827.
Okagawa T, Fujita T, Murakami M, Yamamoto A, Shimura T, Tabata S, Kondo S, Muranishi S. Susceptibility of ebiratide to proteolysis in rat intestinal fluid and homogenates and its protection by various protease inhibitors. Life Sci. 1994;55(9):677-83. PubMed PMID: 8065230.
Matsumoto T, Tsuda S, Nakamura S. The neurotrophic effects of ebiratide, an analog of ACTH4-9, on cultured septal cells and aged rats. J Neural Transm Gen Sect. 1995;100(1):1-15. PubMed PMID: 8748659.